Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

A Case Series of Patients With Psoriasis Exposed to Biologic Therapy During Pregnancy: The BIOBADADERM Register and a Review of the Literature.

Echeverría-García B, Nuño-González A, Dauden E, Vanaclocha F, Torrado R, Belinchón I, Pérez-Zafrilla B; Grupo de estudio BIOBADADERM.

Actas Dermosifiliogr. 2017 Mar;108(2):168-170. doi: 10.1016/j.ad.2016.09.004. Epub 2016 Oct 17. Review. English, Spanish. No abstract available.

PMID:
27765165
2.

Possible paradoxical occurrence of inflammatory arthritis in patients with psoriasis treated with biologics: findings in the Biobadaderm cohort.

Ruiz-Genao D, Perez-Zafrilla B, Lopez-Estebaranz JL, Belinchón-Romero I, Carrascosa JM, Ferrán M, Vanaclocha F, Herrera-Ceballos E, García-Doval I; Biobadaderm Study Group.

Br J Dermatol. 2017 Mar;176(3):797-799. doi: 10.1111/bjd.14690. Epub 2016 Oct 17. No abstract available.

PMID:
27120993
3.

Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort.

García-Doval I, Pérez-Zafrilla B, Ferrandiz C, Carretero G, Daudén E, de la Cueva P, Gómez-García FJ, Herrera-Ceballos E, Belinchón-Romero I, Sánchez-Carazo JL, López-Estebaranz JL, Alsina M, Ferrán M, Torrado R, Carrascosa JM, Rivera R, Vanaclocha F; BIOBADADERM Study Group.

J Dermatolog Treat. 2016;27(3):203-9. doi: 10.3109/09546634.2015.1088130. Epub 2015 Sep 25.

PMID:
26367799
4.

Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time.

Carrascosa JM, Rivera N, Garcia-Doval I, Carretero G, Vanaclocha F, Daudén E, Gómez-García FJ, De-la-Cueva-Dobao P, Herrera-Ceballos E, Belinchón I, Alsina M, Sánchez-Carazo JL, Ferrán M, Lopez-Estebaranz JL, Pérez-Zafrilla B, Llamas M, Rivera R, Ferrándiz C; BIOBADADERM Study Group.

Actas Dermosifiliogr. 2015 Oct;106(8):638-43. doi: 10.1016/j.ad.2015.04.013. Epub 2015 Jun 30. English, Spanish.

PMID:
26141003
5.

Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: A cross-sectional study in clinical practice.

Carrascosa JM, Garcia-Doval I, Pérez-Zafrilla B, Carretero G, Vanaclocha F, Daudén E, De la Cueva-Dobao P, Belinchón I, Alsina M, López-Estebaranz JL, Ferrán M, Torrado R, Rivera R, Carazo C, Barboza L, Ferrándiz C; BIOBADADERM Study Group.

J Dermatolog Treat. 2015;26(6):502-6. doi: 10.3109/09546634.2015.1034070. Epub 2015 Apr 17.

PMID:
25886087
6.

Risk of Reactivation of Hepatitis B Virus Infection in Psoriasis Patients Treated With Biologics: A Retrospective Analysis of 20 Cases From the BIOBADADERM Database.

Sanz-Bueno J, Vanaclocha F, García-Doval I, Torrado R, Carretero G, Daudén E, Patricia Ruiz-Genao D, Alsina-Gibert MM, Pérez-Zafrilla B, Pérez-Rial G, Rivera R; members of the BIOBADADERM group.

Actas Dermosifiliogr. 2015 Jul-Aug;106(6):477-82. doi: 10.1016/j.ad.2015.01.010. Epub 2015 Mar 13. English, Spanish.

PMID:
25776200
7.

Human papillomavirus in carcinomas of the tongue: clinical and prognostic implications.

García-de Marcos JA, Pérez-Zafrilla B, Arriaga Á, Arroyo-Rodríguez S, Poblet E.

Int J Oral Maxillofac Surg. 2014 Mar;43(3):274-80. doi: 10.1016/j.ijom.2013.10.016. Epub 2013 Nov 20.

PMID:
24268899
8.

Infections in patients with rheumatic diseases treated with TNF antagonists.

Pérez-Zafrilla B, Carmona L, Gómez-Reino JJ.

Curr Pharm Biotechnol. 2012 Jun;13(8):1418-25. Review.

PMID:
22339219
9.

Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review.

Cruz Fernández-Espartero M, Pérez-Zafrilla B, Naranjo A, Esteban C, Ortiz AM, Gómez-Reino JJ, Carmona L; BIOBADASER Study Group.

Semin Arthritis Rheum. 2011 Dec;41(3):524-33. doi: 10.1016/j.semarthrit.2011.05.003. Review.

PMID:
22152489
10.

Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry.

Pérez-Sola MJ, Torre-Cisneros J, Pérez-Zafrilla B, Carmona L, Descalzo MA, Gómez-Reino JJ; BIOBADASER Study Group.

Med Clin (Barc). 2011 Nov 12;137(12):533-40. doi: 10.1016/j.medcli.2010.11.032. Epub 2011 Apr 22.

PMID:
21514606
11.

Cancer in patients with rheumatic diseases exposed to TNF antagonists.

Carmona L, Abasolo L, Descalzo MA, Pérez-Zafrilla B, Sellas A, de Abajo F, Gomez-Reino JJ; BIOBADASER Study Group; EMECAR Study Group.

Semin Arthritis Rheum. 2011 Aug;41(1):71-80. doi: 10.1016/j.semarthrit.2010.08.005. Epub 2010 Nov 18.

PMID:
21093020
12.

Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review.

Fernández-Espartero MC, Pérez-Zafrilla B, Naranjo A, Esteban C, Ortiz AM, Gómez-Reino JJ, Carmona L; BIOBADASER Study Group.

Semin Arthritis Rheum. 2011 Feb;40(4):330-7. doi: 10.1016/j.semarthrit.2010.06.004. Epub 2010 Sep 22. Review.

PMID:
20864146
13.

Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists.

García-Doval I, Pérez-Zafrilla B, Descalzo MA, Roselló R, Hernández MV, Gómez-Reino JJ, Carmona L; BIOBADASER 2.0 Study Group.

Ann Rheum Dis. 2010 Oct;69(10):1751-5. doi: 10.1136/ard.2009.125658. Epub 2010 Jun 15.

PMID:
20551153
14.

Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy.

Peña-Sagredo JL, Fariñas MC, Perez-Zafrilla B, Cruz-Valenciano A, Crespo M, Joven-Ibañez B, Riera E, Manero-Ruiz FJ, Chalmeta I, Hernández MV, Rodríguez-Gómez M, Maíz O, López R, Cobo T, Pita J, Carmona L, Gonzalez-Gay MA; BIOBADASER and EMECAR Groups.

Clin Exp Rheumatol. 2009 Nov-Dec;27(6):920-5.

PMID:
20149306
15.

[Adverse Reactions Related to the Administration of TNF Inhibitors. Analysis of a Registry of Biologic Therapy].

Pérez-Zafrilla B, Angel Descalzo M, Carmona L; y Grupo de Estudio BIOBADASER.

Reumatol Clin. 2008 May;4(3):90-5. doi: 10.1016/S1699-258X(08)71810-2. Epub 2008 Oct 28. Spanish.

Supplemental Content

Loading ...
Support Center